ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,069Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 917

$794K Total Retail Price of All Prescriptions

Rank: 30 out of 917

567 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 567 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,733 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
AMLODIPINE BESYLATE 625 585 1 5
LOSARTAN POTASSIUM 477 434 2 13
OMEPRAZOLE 472 409 3 4
LISINOPRIL 430 372 4 1
LEVOTHYROXINE SODIUM 404 354 5 3
SIMVASTATIN 361 317 6 2
PRAVASTATIN SODIUM 348 330 7 20
ATORVASTATIN CALCIUM 280 244 8 14
HYDROCODONE-ACETAMINOPHEN 263 218 S3 9 6
METOPROLOL SUCCINATE 257 229 10 18
CRESTOR 239 195 11 30
WARFARIN SODIUM 221 214 12 10
CARVEDILOL 220 214 13 33
FUROSEMIDE 216 172 14 7
METFORMIN HCL 198 163 15 8
HYDROCHLOROTHIAZIDE 197 190 16 9
CITALOPRAM HBR 183 161 17 15
GABAPENTIN 182 125 18 17
ALLOPURINOL 154 121 19 31
ZOLPIDEM TARTRATE 144 109 20 21
POTASSIUM CHLORIDE 144 134 20 16
TRAZODONE HCL 135 95 22 22
PROAIR HFA 135 66 22 35
MELOXICAM 134 91 24 53
DONEPEZIL HCL 132 118 25 32
SPIRONOLACTONE 130 104 26 55
ALENDRONATE SODIUM 126 113 27 23
RANITIDINE HCL 124 113 28 29
METOPROLOL TARTRATE 120 112 29 11
METFORMIN HCL ER 115 96 30 69
LOSARTAN-HYDROCHLOROTHIAZIDE 113 110 31 62
SPIRIVA 113 77 31 45
FLUTICASONE PROPIONATE 110 87 33 26
DOXAZOSIN MESYLATE 103 100 34 74
JANUVIA 98 80 35 81
TRAMADOL HCL 93 84 36 28
METHADONE HCL 91 57 S2 37 59
CYMBALTA 91 51 37 56
SERTRALINE HCL 91 72 37 24
KLOR-CON 10 76 66 40 115
PANTOPRAZOLE SODIUM 73 43 41 44
FLUOXETINE HCL 70 39 42 38
ATENOLOL 68 55 43 12
OXYCODONE-ACETAMINOPHEN 67 46 S2 44 46
TAMSULOSIN HCL 66 61 45 25
TRIAMTERENE-HCTZ 65 61 46 36
NORTRIPTYLINE HCL 64 48 47 136
OXYCODONE HCL 63 32 S2 48 27
VENLAFAXINE HCL ER 62 23 49 78
PREDNISONE 61 52 50 34
CLOPIDOGREL 59 57 51 50
VOLTAREN 58 52 52 149
VESICARE 55 50 53 166
MIRTAZAPINE 55 55 53 39
FINASTERIDE 55 50 53 77
NAMENDA 54 54 56 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 51 56 42
FENOFIBRATE 52 31 58 73
DIOVAN 52 45 58 49
MORPHINE SULFATE ER 52 36 S2 58 48
DIGOXIN 51 49 61 41
LANTUS SOLOSTAR 50 32 62 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.